Skip to main content

Table 2 Clinical and Laboratory data for the diabetic subjects during treatment period by Group

From: Family physician and endocrinologist coordination as the basis for diabetes care in clinical practice

  Baseline 6 12 18 24 30 months
BMI (Kg.m-2)       
- Group A 28 (25–31) 28 (25–32) 28 (25–32) 28 (25–32) 28 (26–32) 28 (25–32)
- Group B 29 (27–34) 30 (27–32)& 30 (27–33)& 30 (27–32)& 30 (28–36)& 30 (27–35)&
Waist Circumference(cm)       
- Group A       
   Men 103 (96–109) 104 (98–109) 102 (97–108) 102 (92–109) 103 (97–109) 103 (97–112)
   Women 100 (88–114) 96 (87–113) 95 (86–110) 98 (81–113) 99 (81–114) 98 (80–115)
-Group B       
   Men 103 (99–113) 106 (98–115) 106 (98–113)& 103 (99–114) 103 (98–111) 104 (95–118)
   Women 100 (89–114) 104 (84–118)& 110 (83–128)& 107 (82–125)& 101 (78–127) 99 (79–126)
SBP mm Hg       
- Group A 140 (135–155) 137 (130–144) 135 (125–144)* 135 (125–145)* 135 (125–144)* 130 (125–135)**
- Group B 145 (132–160) 138 (128–150)* 135 (127–150)* 132 (125–144)** 135 (125–145)** 135 (121–147)*
DBP mm Hg       
- Group A 80 (75–87) 76 (70–80)* 75 (70–80)* 78 (70–80) 78 (70–80) 76 (71–80)*
- Group B 85 (76–90) 79 (70–84) * 78 (71–80)* 77 (70–79)* 77 (69–78)* 78 (68–79)*
HbA1c (%)       
- Group A 7.2 (6.5–8.5) 7.0 (6.6–7.9) 7.0 (6.6–7.8) 6.9 (6.4–7.8) 7.1 (6.4–7.9) 7.3 (6.5–7.9)
- Group B 7.5 (6.5–9.2) 7.3 (6.3–8.2) 7.4 (6.4–8.0) 7.0 (6.3–8.2)* 7.3 (6.4–8.0) 7.1(6.4–8.3)*
ACR (mg/g)       
- Group A 22 (8–145) 20 (8–99) 22 (9–66) 15 (9–76) 19 (8–86) 27 (9–97)
- Group B 25 (7–128) 29 (10–137) 25 (8–135) 25 (8–141) 20 (11–105) 25 (9–158)
Total Cholesterol (mg/dl)       
- Group A 181 (158–208) 165 (151–182)* 165 (150–183)* 155 (135–175)* 154 (129–166)* 148 (135–163)**
- Group B 189 (164–217) 167 (151–200)* 170 (147–185)* 159 (141–178)** 158 (132–182)** 160 (143–185) **
HDL-Cholesterol (mg/dl)       
-Group A       
   Men 46 (41–55) 46 (43–56) 50 (43–57) 50 (43–56) 46 (40–54) 48 (40–55)
   Women 55 (48–65) 59 (51–71) 58 (49–65) 64 (50–66) 63 (56–68) 56 (54–64)
-Group B       
   Men 49 (39–54) 49 (42–55) 50 (44–53) 50 (43–54) 50 (47–55) 50 (45–55)
   Women 50 (42–60) 53 (45–64) 45 (43–58) 48 (42–58) 48 (37–55) 52 (43–57)
LDL-Cholesterol (mg/dl)       
- Group A 104 (87–128) 93 (83–107) 88 (75–104)* 77 (66–95)** 75 (64–94)** 78 (69–86)**
- Group B 107 (87–136) 96 (78–112)* 91 (77–109)* 82 (72–99)** 80 (64–98)** 81 (70–97) **
Triglycerides (mg/dl)       
- Group A 102 (85–145) 98 (74–149) 112 (77–139) 108 (71–138) 100 (80–141) 97 (75–137)
- Group B 119 (86–160) 105 (87–160) 109 (80–160) 116 (79–158) 117 (79–152) 105 (79–150)
  1. Group A, diabetic patients treated by endocrinology service. Group B, diabetic patients treated by coordinated team, FP and endocrinologist, at primary care site. Data expressed as median (Q1–Q3).
  2. BMI, body mass index. SBP, Systolic Blood Pressure. DBP, Diastolic Blood Pressure. ACR, albumine-to-creatinine ratio.
  3. *p < 0.05, ** p < 0.01, denote differences in relation to baseline values. &p < 0.05 denote differences between Group A vs. Group B.